What is CBC (Cannabichromene)?

Cannabichromene (CBC) is a non-psychoactive cannabinoid found in cannabis plants that typically comprises 0.3% or less of the total cannabinoid content in most strains. As one of the six major cannabinoids alongside THC, CBD, CBG, CBN, and THCV, CBC is formed when cannabigerolic acid (CBGA) is converted by the enzyme cannabichromene synthase. Unlike THC, CBC does not produce intoxicating effects because it binds poorly to CB1 receptors in the brain. Instead, research suggests CBC interacts with TRPV1 and TRPA1 receptors, as well as CB2 receptors in the peripheral nervous system. This unique receptor interaction profile has made CBC a subject of scientific interest, though research remains in early stages. CBC concentrations are generally higher in younger cannabis plants and decrease as the plant matures. Some specialty strains have been bred to contain elevated CBC levels, with certain cultivars reaching up to 1-2% CBC content. The cannabinoid is typically found alongside other minor cannabinoids in full-spectrum cannabis extracts. The cannabis industry has shown growing interest in CBC-focused products, particularly in markets emphasizing minor cannabinoid diversity. Several licensed producers have developed CBC isolates and distillates for use in formulated products, though these remain niche compared to THC and CBD products. From a market perspective, CBC's commercial value is primarily derived from its inclusion in broad-spectrum formulations rather than as a standalone product. Current market pricing for CBC isolates ranges significantly higher than major cannabinoids due to lower yields and specialized extraction requirements. *Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult healthcare professionals before using cannabis products for any health-related purposes.*